Ajer Jeffrey Robert 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed May 6, 2024
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Award
Common Stock
2024-04-30$68.65/sh+300$20,594→ 71,767 total - Sale
Common Stock
2024-05-02$82.91/sh−5,000$414,550→ 66,767 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.